HAS2 and melanoma: The tumor-promoting properties of these transcriptional regulators, and the ability of the HA/CD44 axis to promote their expression in response to BMP stimulation, likely underlies the association between coordinate expression of Id1/Id3 and HAS2/HAS3/CD44, and reduced survival of melanoma patients.